Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 8
2003 7
2004 10
2005 11
2006 6
2007 3
2008 11
2009 6
2010 11
2011 10
2012 4
2013 6
2014 10
2015 4
2016 8
2017 5
2018 9
2019 3
2020 4
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

134 results
Results by year
Filters applied: . Clear all
Page 1
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Sartore-Bianchi A, Trusolino L, Martino C, Bencardino K, Lonardi S, Bergamo F, Zagonel V, Leone F, Depetris I, Martinelli E, Troiani T, Ciardiello F, Racca P, Bertotti A, Siravegna G, Torri V, Amatu A, Ghezzi S, Marrapese G, Palmeri L, Valtorta E, Cassingena A, Lauricella C, Vanzulli A, Regge D, Veronese S, Comoglio PM, Bardelli A, Marsoni S, Siena S. Sartore-Bianchi A, et al. Among authors: comoglio pm. Lancet Oncol. 2016 Jun;17(6):738-746. doi: 10.1016/S1470-2045(16)00150-9. Epub 2016 Apr 20. Lancet Oncol. 2016. PMID: 27108243 Free article. Clinical Trial.
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.
Gallo S, Vitacolonna A, Bonzano A, Comoglio P, Crepaldi T. Gallo S, et al. Among authors: comoglio p. Int J Mol Sci. 2019 May 1;20(9):2164. doi: 10.3390/ijms20092164. Int J Mol Sci. 2019. PMID: 31052420 Free PMC article. Review.
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies.
Apicella M, Giannoni E, Fiore S, Ferrari KJ, Fernández-Pérez D, Isella C, Granchi C, Minutolo F, Sottile A, Comoglio PM, Medico E, Pietrantonio F, Volante M, Pasini D, Chiarugi P, Giordano S, Corso S. Apicella M, et al. Among authors: comoglio pm. Cell Metab. 2018 Dec 4;28(6):848-865.e6. doi: 10.1016/j.cmet.2018.08.006. Epub 2018 Aug 30. Cell Metab. 2018. PMID: 30174307 Free article.
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
Moran S, Martínez-Cardús A, Sayols S, Musulén E, Balañá C, Estival-Gonzalez A, Moutinho C, Heyn H, Diaz-Lagares A, de Moura MC, Stella GM, Comoglio PM, Ruiz-Miró M, Matias-Guiu X, Pazo-Cid R, Antón A, Lopez-Lopez R, Soler G, Longo F, Guerra I, Fernandez S, Assenov Y, Plass C, Morales R, Carles J, Bowtell D, Mileshkin L, Sia D, Tothill R, Tabernero J, Llovet JM, Esteller M. Moran S, et al. Among authors: comoglio pm. Lancet Oncol. 2016 Oct;17(10):1386-1395. doi: 10.1016/S1470-2045(16)30297-2. Epub 2016 Aug 27. Lancet Oncol. 2016. PMID: 27575023
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.
Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, Isella C, Corà D, Di Nicolantonio F, Buscarino M, Petti C, Ribero D, Russolillo N, Muratore A, Massucco P, Pisacane A, Molinaro L, Valtorta E, Sartore-Bianchi A, Risio M, Capussotti L, Gambacorta M, Siena S, Medico E, Sapino A, Marsoni S, Comoglio PM, Bardelli A, Trusolino L. Bertotti A, et al. Among authors: comoglio pm. Cancer Discov. 2011 Nov;1(6):508-23. doi: 10.1158/2159-8290.CD-11-0109. Epub 2011 Sep 2. Cancer Discov. 2011. PMID: 22586653 Free article.
Genetic link between cancer and thrombosis.
Boccaccio C, Comoglio PM. Boccaccio C, et al. Among authors: comoglio pm. J Clin Oncol. 2009 Oct 10;27(29):4827-33. doi: 10.1200/JCO.2009.22.7199. Epub 2009 Sep 8. J Clin Oncol. 2009. PMID: 19738115 Review.
Invasive growth: a genetic program.
Gentile A, Comoglio PM. Gentile A, et al. Among authors: comoglio pm. Int J Dev Biol. 2004;48(5-6):451-6. doi: 10.1387/ijdb.041799ag. Int J Dev Biol. 2004. PMID: 15349819 Free article. Review.
134 results